Companies:
53,025
Total Market Cap:
168990429785205.08
Global Rank
#19182
Country Rank
#644
Market Cap
283.74 M
Price
21.11
Change (%)
0.32%
Volume
124,003
HansBiomed's latest marketcap:
283.74 M
As of 04/30/2026, HansBiomed's market capitalization has reached $283.74 M. According to our data, HansBiomed is the 19182th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 283.74 M |
| Revenue (ttm) | 67.79 M |
| Net Income (ttm) | -18,572,437.84 |
| Shares Out | 14.26 M |
| EPS (ttm) | -1.42 |
| Forward PE | 27.68 |
| Ex-Dividend Date | 09/27/2019 |
| Earnings Date | 05/15/2026 |
Market Cap Chart
Data Updated: 04/30/2026
HansBiomed's yearly market capitalization.
HansBiomed has seen its market value grow from ₩149.27 B to ₩375.07 B since 2014, representing a total increase of 151.28% and an annual compound growth rate (CAGR) of 8.40%.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 06/02/2026 | ₩375.07 B | $247.82 M | -0.71% | n/a |
| 12/30/2025 | ₩377.76 B | $256.7 M | 229.79% | 24403 |
| 12/30/2024 | ₩114.55 B | $76.75 M | -39.92% | 25042 |
| 12/28/2023 | ₩190.65 B | $146.8 M | 100.91% | 20685 |
| 12/29/2022 | ₩94.89 B | $74.97 M | -16.49% | 24152 |
| 12/30/2021 | ₩113.63 B | $95.45 M | -16.24% | 23397 |
| 12/30/2020 | ₩135.66 B | $0 | -44.87% | 19341 |
| 12/30/2019 | ₩246.08 B | $211.63 M | 4.52% | 14503 |
| 12/28/2018 | ₩235.43 B | $209.54 M | -18.17% | 13691 |
| 12/28/2017 | ₩287.7 B | $267.56 M | 87.42% | 13359 |
Company Profile
About HansBiomed Corporation
HansBiomed Corporation, together with its subsidiaries, specializes in the research, development, production, and sale of medical materials for procedures and raw materials for medical supplies.
Key Products & Solutions
- ExFuse – Demineralized bone matrix with cancellous bone gel/putty.
- BellaFuse – Demineralized bone matrix.
- Genesis – Cancellous sponge block/filler.
- Pedi-Stick – Demineralized cortical bone stick.
- SureChip – Cancellous bone chip.
- OsteoGrow – Demineralized bone matrix inserter.
- BellaCell HD – Allograft dermal product for skin loss due to breast cancer.
- SureDerm – Acellular dermal matrix.
- BELLAGEL – Breast prosthesis, internal, and gel-filled solution.
- MINT Lift – PDO thread.
- EZ-Tcon Solution
- Lion HT/HN – Hair transplanter body/needle.
- Scar Clinic – Scar management solution.
Company Background
Originally founded in 1990 as Hans Medical Corp., the company rebranded to HansBiomed Corporation in June 2000. It is headquartered in Seoul, South Korea.
Frequently Asked Questions
-
What is HansBiomed's (KOSDAQ-042520) current market cap?As of 04/30/2026, HansBiomed (including the parent company, if applicable) has an estimated market capitalization of $283.74 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does HansBiomed (KOSDAQ-042520) rank globally by market cap?HansBiomed global market capitalization ranking is approximately 19182 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.